The Novacyt Group is a rapidly growing, international diagnostics group with a growing portfolio of cancer and infectious disease products and services. Through its proprietary technology platform, NOVAPrep®, and molecular platform, genesig®, Novacyt is able to provide an extensive range of oncology and infectious disease diagnostic products across an extensive international distributor network. The Group has diversified sales from diagnostic reagents used in oncology, microbiology, haematology and serology markets, and its global customers and partners include major corporates.
| CFO: |
Steve Gibson |
| Chief Executive Officer : |
Lyn Rees |
| Executive Director: |
Joanne Mason |
| Independent Non-Executive Director: |
Jean-Pierre Crinelli , Juliet Thompson |
| Non-Executive Chairman: |
John Brown |
| Non-Executive Director: |
Ian David Gilham |
| Address: |
131 Boulevard Carnot, Le Vésinet, France |
| Phone: |
+33 (0)1 39 46 51 04 |
| Fax: |
+ 33 (0)1 30 70 05 32 |
| Website: |
http://novacyt.com/ |
| Email: |
|